Kaiser to launch Phase 3 testing of coronavirus vaccine in 1,400 California and Oregon adults
Excerpt from the Press Release:
Kaiser Permanente has joined a Phase 3 clinical trial to test a coronavirus vaccine candidate currently in production by Pfizer and BioNTech, and will seek to enroll 1,400 adults aged 18-85 in California and Oregon to join in the study, a press release from the medical organization states. The aim of the trial is to enlist 30,000 patients in 120 sites around the world to participate.
According to Kaiser’s research study database, a portion of these vaccine candidates will be administered in Northern California at the Santa Clara Medical Center and the Sacramento Medical Center. Enrollment for the trial has not yet begun.
Click the button below to read the Press Release:
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?